Several overseas research institutes have conducted “replication studies” using N-NOSE, the world’s first biological screening technology, focusing on the reproducibility of our method.
The research confirmed that the technology is reproducible as a method of identifying cancer with great accuracy, and results have been published in academic journals.
On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queens . . .2022.06.08
We have formed a business alliance with Sojitz Corporation.→PRESS RELEASE2022.03.11
We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare pr . . .2022.03.11